Department of Urology, Wenling Hospital Affiliated to Wenzhou Medical University (The First People's Hospital of Wenling), Taizhou, China.
Department of Surgical Operating Room, Wenling Hospital Affiliated to Wenzhou Medical University (The First People's Hospital of Wenling), Taizhou, China.
Neurourol Urodyn. 2024 Nov;43(8):2214-2221. doi: 10.1002/nau.25543. Epub 2024 Jul 8.
The purpose of this study was to examine the association between blood lead levels and the prevalence of nocturia in American adults.
We analyzed data from the National Health and Nutrition Examination Survey (NHANES) from 2005 to 2020, focusing on individuals aged 20 years or older (n = 11,919). Blood lead levels were categorized into two groups (<2 µg/dL and ≥2 µg/dL), and the presence of nocturia was assessed based on questionnaire responses. We used multivariable logistic regression models to explore the association between blood lead levels and nocturia while adjusting for various covariates, including sex, ratio of family income to poverty (RIP), lipid profile, age, body mass index (BMI), race, citizenship, sleep trouble, diabetes, and hypertension. To verify whether certain covariates influence blood lead levels and the risk of nocturia, we conducted subgroup analyses.
Of the study participants, 31.70% reported experiencing nocturia. Individuals with higher blood lead levels (≥2 µg/dL) exhibited a higher likelihood of experiencing nocturia compared to those with lower levels (<2 µg/dL) in all three models (Model 1: OR 1.46, 95% CI 1.29-1.66, p < 0.0001; Model 2: OR 1.25, 95% CI 1.09-1.44, p = 0.002; Model 3: OR 1.22, 95%CI 1.06-1.41, p = 0.01). Subgroup analyses revealed that factors such as age, sex, sleep trouble, diabetes, hypertension, BMI, RIP, and race did not affect the association between blood lead levels and the risk of nocturia (P for interaction >0.05).
This study reported the correlation between blood lead levels and nocturia. We found that compared to blood lead levels below 2 µg/dL, when lead levels reached or exceeded 2 µg/dL, the risk of nocturia occurrence increased by 22%.
This study is based on existing data from a public database and not from a specific clinical trial; hence, clinical registration information is not provided.
本研究旨在探讨美国成年人血铅水平与夜尿症患病率之间的关联。
我们分析了 2005 年至 2020 年国家健康和营养调查(NHANES)的数据,重点关注年龄在 20 岁及以上的个体(n=11919)。血铅水平分为两组(<2μg/dL 和≥2μg/dL),并根据问卷回答评估夜尿症的存在。我们使用多变量逻辑回归模型,在调整性别、家庭收入与贫困比例(RIP)、血脂谱、年龄、体重指数(BMI)、种族、公民身份、睡眠问题、糖尿病和高血压等各种协变量的情况下,探讨血铅水平与夜尿症之间的关联。为了验证某些协变量是否会影响血铅水平和夜尿症的风险,我们进行了亚组分析。
在研究参与者中,31.70%报告有夜尿症。与血铅水平较低(<2μg/dL)的个体相比,血铅水平较高(≥2μg/dL)的个体在所有三个模型中发生夜尿症的可能性更高(模型 1:OR 1.46,95%CI 1.29-1.66,p<0.0001;模型 2:OR 1.25,95%CI 1.09-1.44,p=0.002;模型 3:OR 1.22,95%CI 1.06-1.41,p=0.01)。亚组分析表明,年龄、性别、睡眠问题、糖尿病、高血压、BMI、RIP 和种族等因素并不影响血铅水平与夜尿症风险之间的关联(交互作用 P>0.05)。
本研究报告了血铅水平与夜尿症之间的相关性。我们发现,与血铅水平低于 2μg/dL 相比,当铅水平达到或超过 2μg/dL 时,夜尿症发生的风险增加了 22%。
本研究基于公共数据库中现有数据,而不是特定临床试验的数据,因此未提供临床注册信息。